Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01823874 · ClinicalTrials.gov registry record · NA
Firsthand ID for Pain Control
A NA study of Virtual Reality Pain Distraction, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT01823874: Completed NA study of Virtual Reality Pain Distraction, sponsored by University of Washington.
NCT01823874 is a NA study of Virtual Reality Pain Distraction that has completed, run by University of Washington. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01823874, a NA study of Virtual Reality Pain Distraction, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Clinical benefits of VR analgesia have been empirically demonstrated as either an alternative or in combination with opioids. Issues of cost, ergonomics, and maintenance of the hardware systems have limited the wider use of this benefit to the public. Firsthand Technology has designed a system to meet the performance requirements for high levels of pain control in a durable, ergonomic package at a greatly reduced cost compared to the current systems in use. This study will validate the new system by running a thermal pain study that tests the effect of the new system (ID) compared to the established standard helmet currently used.
Primary Outcome
Rating scales will determine levels of pain, fun, and nausea experienced.
Conditions Studied
Interventions
- PROCEDURE virtual reality distraction
Study Locations (1)
Washington
- University of Washington Oral Medicine Clinic - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-04 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT01823874 record still lists
NCT01823874 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Virtual Reality Pain Distraction appearing as the primary indexed condition, and to 1 intervention - of which virtual reality distraction is the first listed.
NCT01823874 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01823874 about?
NCT01823874 is a clinical study titled "Firsthand ID for Pain Control". Clinical benefits of VR analgesia have been empirically demonstrated as either an alternative or in combination with opioids. Issues of cost, ergonomics, and maintenance of the hardware systems have limited the wider use of this benefit to the public. Firsthand Technology has designed a system to me...
What is the current status of trial NCT01823874?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2013-04. Estimated completion is 2013-12.
What conditions does trial NCT01823874 study?
This clinical trial studies the following conditions: Virtual Reality Pain Distraction.
What interventions are being tested in trial NCT01823874?
The interventions under investigation include: virtual reality distraction (PROCEDURE).
Who is sponsoring clinical trial NCT01823874?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01823874 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01823874's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia